2. Immunology/Inflammation Cell Cycle/DNA Damage
  3. Interleukin Related DNA/RNA Synthesis
  4. CK-102

CK-102 is an interleukin-1 (IL-1) inhibitor. CK-102 reduces mRNA synthesis. CK-102 does not inhibit DNA synthesis. CK-102 only slightly inhibits protein synthesis, or has no effect on it. CK-102 delays wound healing after ophthalmic surgery and prolongs the failure time of trabeculectomy fistulas. CK-102 inhibits lens protein-induced ocular inflammation at both early and late stages. CK-102 inhibits endotoxin-induced uveitis. CK-102 does not inhibit interleukin-1-induced uveitis. CK-102 can be used in research related to glaucoma filtration failure and uveitis.

For research use only. We do not sell to patients.

CK-102

CK-102 Chemical Structure

CAS No. : 6236-97-1

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

CK-102 Related Antibodies

Top Publications Citing Use of Products

View All Interleukin Related Isoform Specific Products:

View All Isoforms
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22 IL-18

View All DNA/RNA Synthesis Isoform Specific Products:

View All Isoforms
RNASE L DNA Polymerases RNA Polymerases Helicases DNA Ligase

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

CK-102 is an interleukin-1 (IL-1) inhibitor. CK-102 reduces mRNA synthesis. CK-102 does not inhibit DNA synthesis. CK-102 only slightly inhibits protein synthesis, or has no effect on it. CK-102 delays wound healing after ophthalmic surgery and prolongs the failure time of trabeculectomy fistulas. CK-102 inhibits lens protein-induced ocular inflammation at both early and late stages. CK-102 inhibits endotoxin-induced uveitis. CK-102 does not inhibit interleukin-1-induced uveitis. CK-102 can be used in research related to glaucoma filtration failure and uveitis[1][2][3].

IC50 & Target[1]

IL-1

 

In Vitro

CK-102 (10-100 μg/mL; 24-72 h) inhibits proliferation of SIRC rabbit corneal fibroblast cells in a non-cytolytic manner, with viable cell counts remaining at or above initial levels while growing more slowly than controls across 10, 30, and 100 μg/mL concentrations at 24, 48, and 72 h[1].
CK-102 (10-100 μg/mL; 24-72 h) produces limited, inconsistent inhibition of DNA synthesis, transient inhibition of RNA synthesis at 24 and 48 h, and variable effects on protein synthesis (with occasional reduction or increase) in SIRC rabbit corneal fibroblast cells across 10, 30, and 100 μg/mL concentrations at 24, 48, and 72 h[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

CK-102 Related Antibodies

Cell Proliferation Assay[1]

Cell Line: SIRC rabbit corneal fibroblast cells
Concentration: 10 μg/mL; 30 μg/mL; 100 μg/mL
Incubation Time: 24 h; 48 h; 72 h
Result: Reduced viable cell numbers compared to controls at each time point.
Inhibited cell proliferation, with growth reduced initially but recovering later and proceeding at a slower rate than controls.
Maintained viable cell counts at or above the starting cell count, confirming no cytolytic effect.
In Vivo

CK-102 (10 mg; subTenons injection; single dose; immediately after surgery) administered as a single 10 mg subTenons injection immediately after trabeculectomy statistically significantly prolongs the time to filtration fistula failure by 30% in Dutch Belted rabbits with no observed side effects[2].
CK-102 (1%; topical; single instillation; 1 hour prior to lens protein challenge) significantly suppresses both early and late phases of lens protein-induced uveitis in Oryctolagus cuniculus, with comparable efficacy to Prednisolone (HY-17463)[3].
CK-102 (10 mg/kg; i.p.; three times daily) significantly suppresses endotoxin-induced uveitis in rats, with greater potency than Prednisolone at an equivalent dose[3].
CK-102 (10 mg/kg; i.p.; three times daily) does not suppress interleukin-1-induced uveitis in rats[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Dutch Belted (adult, specific pathogen free for Pasteurellosis, glaucoma model via bilateral partial thickness trabeculectomy filtration surgery)[2]
Dosage: 10 mg
Administration: subTenons injection; single dose; immediately after surgery
Result: Prolonged the mean number of days to filtration fistula failure by 30% compared to vehicle control, with statistical significance.
Showed no side effects at the tested dose.
Animal Model: New Zealand albino rabbits (either sex, 2.0 to 3.0 kg)[3]
Dosage: 1%
Administration: topical; single instillation; 1 hour prior to lens protein challenge
Result: Significantly suppressed fluorescein concentration (a marker of inflammation) in the anterior chamber at all measured time points (30, 60, 120, 180, 240, 300, 360 minutes) compared to solvent control, with mean values consistently lower than control.
Suppressed both early (0-3 hour) and late (4-5 hour) phases of inflammation.
Animal Model: Sprague-Dawley rats (250-350 grams)[3]
Dosage: 10 mg/kg
Administration: i.p.; three times daily; at 0, 4, and 10 hours after endotoxin injection
Result: Significantly suppressed uveitis responses (measured via fluorescein concentration) at 1.5, 2, 3, 4, 5, and 6 hours after fluorescein injection, with mean fluorescein concentrations consistently lower than control.
Observed no obvious side effects during the experiment.
Animal Model: Sprague-Dawley rats (250-350 grams)[3]
Dosage: 10 mg/kg
Administration: i.p.; three times daily; at 0, 4, and 10 hours after interleukin-1 injection
Result: Did not significantly affect interleukin-1-induced uveitis; fluorescein concentrations in treated rats were not statistically different from control values at any measured time point.
Molecular Weight

223.28

Formula

C15H13NO
CAS No.
SMILES

O=C1C=2C=CC=CC2NC=3C1=CC=C(C3C)C
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

CK-102 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CK-1026236-97-1CK102CK 102Interleukin RelatedDNA/RNA SynthesisILendotoxin-induced uveitisinterleukin-1fibroblast proliferationSIRC rabbit corneal fibroblast cellstrabeculectomy fistula failurecorneal fibroblastsDutch Belted rabbitsocular inflammationuveitisglaucoma filtration failureInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
CK-102
Cat. No.:
HY-121303
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.